University of Cincinnati

What you'll study

The programme combines foundational pharmaceutical sciences with specialised tracks that can include pharmaceutics and drug delivery, medicinal chemistry, pharmacology and toxicology, clinical and translational sciences, and regulatory science and pharmaceutical policy. Students complete core coursework in areas such as advanced pharmacokinetics, drug formulation and delivery, research design and biostatistics, and principles of drug metabolism and toxicology.

Most students choose between a thesis (research) and non‑thesis (professional) option. The thesis route emphasises laboratory or translational research under faculty supervision, including original research, seminar presentation and a formal defence. The non‑thesis path focuses on advanced coursework, a practicum or capstone project, and may include industry‑oriented courses in regulatory affairs, quality assurance and pharmaceutical management.

Typical learning activities include lab practicums, journal clubs and seminars, elective modules aligned to a chosen concentration, and experiential placements with clinical partners or industry collaborators. Students also engage with cross‑disciplinary resources across the university, including collaborative projects with clinical faculty and access to core research facilities.

Entry requirements

• First degree in pharmacy, chemistry, biochemistry, biology, or a closely related science from an accredited institution.
• A strong academic record at undergraduate level; candidates with varied professional experience in pharmaceutical settings are also considered.
• Academic transcripts, a personal statement outlining research interests and career goals, and at least two academic or professional references.
• Research experience is desirable for applicants to the thesis option; applicants to the non‑thesis/professional option should highlight relevant industry or clinical experience where applicable.
• International applicants must meet English language proficiency requirements as stipulated by the university; additional documentation may be required for visa purposes.
• Standardised test requirements (such as the GRE) are determined by the college and may be waived in many cases; applicants should consult the programme for current policy.

Career prospects

Graduates enter a wide range of roles across the pharmaceutical, biotechnology and healthcare sectors. Common career paths include formulation and process development, analytical and quality control, regulatory affairs, clinical research coordination and clinical data management, pharmacovigilance, and medical or scientific communications.

The programme also prepares students for further research training at the doctoral level and for roles in government regulatory agencies, contract research organisations (CROs), and hospital‑based research units. Employers value the combination of scientific rigour and applied training, which supports transitions into project management, product development and translational research roles.

Why study at University of Cincinnati

• Established pharmacy college: The programme is housed within a college with a long history of pharmacy education and active research programmes in drug discovery and clinical sciences.
• Research infrastructure: Access to well‑equipped laboratories, core facilities and multidisciplinary research centres supports hands‑on training in formulation, analytical methods, pharmacology and translational projects.
• Clinical and industry links: Close relationships with local hospitals, clinical partners and regional biopharma companies provide opportunities for experiential placements, collaborative research and professional networking.
• Flexible pathways: Thesis and non‑thesis options accommodate students focused on research or those aiming for industry and regulatory careers.
• Professional development: The university offers career services, seminars and connections to alumni and employer networks that help students secure internships and positions in the pharmaceutical and healthcare sectors.